Seek Returns logo

CI vs. GH: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at CI and GH, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolCIGH
Company NameThe Cigna GroupGuardant Health, Inc.
CountryUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS IndustryHealth Care Providers & ServicesHealth Care Providers & Services
Market Capitalization76.64 billion USD7.30 billion USD
ExchangeNYSENasdaqGS
Listing DateMarch 31, 1982October 4, 2018
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of CI and GH by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

CI vs. GH: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolCIGH
5-Day Price Return5.94%16.23%
13-Week Price Return-9.07%40.59%
26-Week Price Return-0.05%27.08%
52-Week Price Return-12.50%92.22%
Month-to-Date Return7.38%42.92%
Year-to-Date Return3.97%91.72%
10-Day Avg. Volume2.48M4.09M
3-Month Avg. Volume1.90M2.42M
3-Month Volatility33.87%54.49%
Beta0.471.57

Profitability

Return on Equity (TTM)

CI

12.27%

Health Care Providers & Services Industry

Max
26.03%
Q3
13.74%
Median
8.26%
Q1
4.13%
Min
-3.62%

CI’s Return on Equity of 12.27% is on par with the norm for the Health Care Providers & Services industry, indicating its profitability relative to shareholder equity is typical for the sector.

GH

-246.60%

Health Care Providers & Services Industry

Max
26.03%
Q3
13.74%
Median
8.26%
Q1
4.13%
Min
-3.62%

GH has a negative Return on Equity of -246.60%. This indicates the company is generating a loss for its shareholders, which can be a result of unprofitability or negative shareholder equity and is often a sign of financial distress.

CI vs. GH: A comparison of their Return on Equity (TTM) against the Health Care Providers & Services industry benchmark.

Net Profit Margin (TTM)

CI

1.92%

Health Care Providers & Services Industry

Max
12.40%
Q3
5.93%
Median
1.96%
Q1
0.93%
Min
-6.10%

CI’s Net Profit Margin of 1.92% is aligned with the median group of its peers in the Health Care Providers & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.

GH

-49.93%

Health Care Providers & Services Industry

Max
12.40%
Q3
5.93%
Median
1.96%
Q1
0.93%
Min
-6.10%

GH has a negative Net Profit Margin of -49.93%, indicating the company is operating at a net loss as its expenses exceeded its revenues.

CI vs. GH: A comparison of their Net Profit Margin (TTM) against the Health Care Providers & Services industry benchmark.

Operating Profit Margin (TTM)

CI

3.41%

Health Care Providers & Services Industry

Max
19.05%
Q3
10.21%
Median
4.22%
Q1
1.98%
Min
-4.27%

CI’s Operating Profit Margin of 3.41% is around the midpoint for the Health Care Providers & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.

GH

-54.54%

Health Care Providers & Services Industry

Max
19.05%
Q3
10.21%
Median
4.22%
Q1
1.98%
Min
-4.27%

GH has a negative Operating Profit Margin of -54.54%. This signifies the company is unprofitable at the operational level, as its core business expenses exceed its revenue.

CI vs. GH: A comparison of their Operating Profit Margin (TTM) against the Health Care Providers & Services industry benchmark.

Profitability at a Glance

SymbolCIGH
Return on Equity (TTM)12.27%-246.60%
Return on Assets (TTM)3.26%-29.04%
Net Profit Margin (TTM)1.92%-49.93%
Operating Profit Margin (TTM)3.41%-54.54%
Gross Profit Margin (TTM)9.86%62.84%

Financial Strength

Current Ratio (MRQ)

CI

0.79

Health Care Providers & Services Industry

Max
2.01
Q3
1.49
Median
1.30
Q1
0.94
Min
0.17

CI’s Current Ratio of 0.79 falls into the lower quartile for the Health Care Providers & Services industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

GH

3.71

Health Care Providers & Services Industry

Max
2.01
Q3
1.49
Median
1.30
Q1
0.94
Min
0.17

GH’s Current Ratio of 3.71 is exceptionally high, placing it well outside the typical range for the Health Care Providers & Services industry. This indicates a very strong liquidity position, though such a high ratio may also suggest that the company is not using its assets efficiently to generate profits.

CI vs. GH: A comparison of their Current Ratio (MRQ) against the Health Care Providers & Services industry benchmark.

Debt-to-Equity Ratio (MRQ)

CI

0.77

Health Care Providers & Services Industry

Max
2.17
Q3
1.18
Median
0.74
Q1
0.45
Min
0.00

CI’s Debt-to-Equity Ratio of 0.77 is typical for the Health Care Providers & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

GH

16.78

Health Care Providers & Services Industry

Max
2.17
Q3
1.18
Median
0.74
Q1
0.45
Min
0.00

With a Debt-to-Equity Ratio of 16.78, GH operates with exceptionally high leverage compared to the Health Care Providers & Services industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.

CI vs. GH: A comparison of their Debt-to-Equity Ratio (MRQ) against the Health Care Providers & Services industry benchmark.

Interest Coverage Ratio (TTM)

CI

2.32

Health Care Providers & Services Industry

Max
14.47
Q3
7.15
Median
5.45
Q1
2.04
Min
-4.44

CI’s Interest Coverage Ratio of 2.32 is positioned comfortably within the norm for the Health Care Providers & Services industry, indicating a standard and healthy capacity to cover its interest payments.

GH

-150.95

Health Care Providers & Services Industry

Max
14.47
Q3
7.15
Median
5.45
Q1
2.04
Min
-4.44

GH has a negative Interest Coverage Ratio of -150.95. This indicates that its earnings were insufficient to cover even its operational costs, let alone its interest payments, signaling significant financial distress.

CI vs. GH: A comparison of their Interest Coverage Ratio (TTM) against the Health Care Providers & Services industry benchmark.

Financial Strength at a Glance

SymbolCIGH
Current Ratio (MRQ)0.793.71
Quick Ratio (MRQ)0.683.19
Debt-to-Equity Ratio (MRQ)0.7716.78
Interest Coverage Ratio (TTM)2.32-150.95

Growth

Revenue Growth

CI vs. GH: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

CI vs. GH: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

CI

2.11%

Health Care Providers & Services Industry

Max
5.38%
Q3
2.22%
Median
0.55%
Q1
0.00%
Min
0.00%

CI’s Dividend Yield of 2.11% is consistent with its peers in the Health Care Providers & Services industry, providing a dividend return that is standard for its sector.

GH

0.00%

Health Care Providers & Services Industry

Max
5.38%
Q3
2.22%
Median
0.55%
Q1
0.00%
Min
0.00%

GH currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

CI vs. GH: A comparison of their Dividend Yield (TTM) against the Health Care Providers & Services industry benchmark.

Dividend Payout Ratio (TTM)

CI

31.63%

Health Care Providers & Services Industry

Max
186.69%
Q3
74.82%
Median
26.76%
Q1
0.00%
Min
0.00%

CI’s Dividend Payout Ratio of 31.63% is within the typical range for the Health Care Providers & Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

GH

0.00%

Health Care Providers & Services Industry

Max
186.69%
Q3
74.82%
Median
26.76%
Q1
0.00%
Min
0.00%

GH has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

CI vs. GH: A comparison of their Dividend Payout Ratio (TTM) against the Health Care Providers & Services industry benchmark.

Dividend at a Glance

SymbolCIGH
Dividend Yield (TTM)2.11%0.00%
Dividend Payout Ratio (TTM)31.63%0.00%

Valuation

Price-to-Earnings Ratio (TTM)

CI

15.01

Health Care Providers & Services Industry

Max
55.89
Q3
30.85
Median
21.17
Q1
12.63
Min
0.00

CI’s P/E Ratio of 15.01 is within the middle range for the Health Care Providers & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

GH

--

Health Care Providers & Services Industry

Max
55.89
Q3
30.85
Median
21.17
Q1
12.63
Min
0.00

P/E Ratio data for GH is currently unavailable.

CI vs. GH: A comparison of their Price-to-Earnings Ratio (TTM) against the Health Care Providers & Services industry benchmark.

Price-to-Sales Ratio (TTM)

CI

0.29

Health Care Providers & Services Industry

Max
3.10
Q3
1.74
Median
0.67
Q1
0.24
Min
0.00

CI’s P/S Ratio of 0.29 aligns with the market consensus for the Health Care Providers & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

GH

8.75

Health Care Providers & Services Industry

Max
3.10
Q3
1.74
Median
0.67
Q1
0.24
Min
0.00

With a P/S Ratio of 8.75, GH trades at a valuation that eclipses even the highest in the Health Care Providers & Services industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.

CI vs. GH: A comparison of their Price-to-Sales Ratio (TTM) against the Health Care Providers & Services industry benchmark.

Price-to-Book Ratio (MRQ)

CI

2.20

Health Care Providers & Services Industry

Max
7.61
Q3
4.32
Median
2.53
Q1
1.14
Min
0.77

CI’s P/B Ratio of 2.20 is within the conventional range for the Health Care Providers & Services industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

GH

35.72

Health Care Providers & Services Industry

Max
7.61
Q3
4.32
Median
2.53
Q1
1.14
Min
0.77

At 35.72, GH’s P/B Ratio is at an extreme premium to the Health Care Providers & Services industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.

CI vs. GH: A comparison of their Price-to-Book Ratio (MRQ) against the Health Care Providers & Services industry benchmark.

Valuation at a Glance

SymbolCIGH
Price-to-Earnings Ratio (TTM)15.01--
Price-to-Sales Ratio (TTM)0.298.75
Price-to-Book Ratio (MRQ)2.2035.72
Price-to-Free Cash Flow Ratio (TTM)11.65--